The global microfluidics market is on track for exceptional expansion, with projections showing a rise from USD 7,711.9 million in 2023 to an extraordinary USD 23,739.1 million by 2033, representing a ...

The global endovenous laser therapy market is on the brink of transformative growth, with projections highlighting a substantial rise in its value. According to a recent survey by Future Market ...

The global widefield imaging systems market is experiencing remarkable growth, with projections indicating an impressive surge from USD 0.6 billion in 2023 to USD 1.4 billion by 2033. This substantial ...

The global western blotting market is on a steady growth trajectory, with market valuation expected to rise from USD 980.1 million in 2023 to USD 1,753.4 million by 2033, marking a robust CAGR of 6% ...

Reaccreditation Highlights OptiMed's Continued Commitment to Excellence in Patient Care and Quality StandardsKALAMAZOO, MI / ...

Striking new figures from the Office for National Statistics (ONS) reveals millennials (people born between around 1981-1996) ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

The global gamma knife market is on a significant growth trajectory, with market size projections reaching USD 702.5 million by 2033, up from USD 337.7 million in 2023. This robust growth reflects a ...

The global balloon catheter market is set to experience substantial growth over the next decade, with a projected compound annual growth rate (CAGR) of 4.3% from 2023 to 2033, according to a new ...

According to a recent study by Future Market Insights (FMI), the global biopsy device market is projected to experience steady, moderate growth over the coming decade. Valued at approximately USD ...

The escalating demand for swift and reliable vascular access solutions is fueling the growth of the intraosseous infusion devices market, which is forecasted to achieve a CAGR of 6.9% over the next ...

DENVER, CO / ACCESSWIRE / November 6, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its ...